APEIRON Capital Ltd’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,115
| Closed | -$1.13M | – | 14 |
|
|
2024
Q4 | $1.13M | Hold |
27,115
| – | – | 0.42% | 12 |
|
|
2024
Q3 | $1.81M | Hold |
27,115
| – | – | 0.65% | 10 |
|
|
2024
Q2 | $3.22M | Buy |
27,115
+20,046
| +284% | +$2.38M | 1.12% | 10 |
|
|
2024
Q1 | $753K | Sell |
7,069
-24,131
| -77% | -$2.57M | 0.38% | 12 |
|
|
2023
Q4 | $3.1M | Buy |
31,200
+15,300
| +96% | +$1.52M | 4.56% | 7 |
|
|
2023
Q3 | $1.64M | Hold |
15,900
| – | – | 1.1% | 9 |
|
|
2023
Q2 | $1.93M | Sell |
15,900
-7,100
| -31% | -$863K | 1.17% | 13 |
|
|
2023
Q1 | $3.53M | Buy |
+23,000
| New | +$3.53M | 1.97% | 9 |
|
|
2022
Q4 | – | Sell |
-91,000
| Closed | -$10.8M | – | 11 |
|
|
2022
Q3 | $10.8M | Hold |
91,000
| – | – | 7.17% | 5 |
|
|
2022
Q2 | $13M | Hold |
91,000
| – | – | 7.95% | 4 |
|
|
2022
Q1 | $15.7M | Hold |
91,000
| – | – | 6.93% | 6 |
|
|
2021
Q4 | $23.1M | Buy |
91,000
+3,100
| +4% | +$787K | 6.81% | 8 |
|
|
2021
Q3 | $33.8M | Buy |
87,900
+5,900
| +7% | +$2.27M | 8.88% | 5 |
|
|
2021
Q2 | $19.3M | Buy |
82,000
+47,000
| +134% | +$11M | 6.24% | 7 |
|
|
2021
Q1 | $4.58M | Buy |
+35,000
| New | +$4.58M | 1.97% | 9 |
|